Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

Presentation TCT 2015

LV to Aorta Pumping: HeartMate PHP

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

HeartMate Percutaneous Heart Pump (PHP) in Cardiogenic Shock Initial Clinical Experience From Prague

Presenter: Andrea Abizaid, Daniel Burkhoff, Jiri Maly

October 14, 2015

Presentation TCT 2015

HeartMate Percutaneous Heart Pump (PHP) in High-Risk Coronary Intervention: Results of the SHIELD I Trial

Presenter: Andrea Abizaid, Daniel Burkhoff, Dariusz Dudek

October 14, 2015

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

News Industry News

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

September 04, 2015

News Industry News

Thoratec Receives CE Mark Approval For HeartMate PHP™

July 13, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

News Industry News

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

September 09, 2014

News Industry News

Thoratec Announces Start Of The HeartMate PHP™ CE Mark Trial

August 06, 2014

News Industry News

JARVIK HEART Announces Full FDA Approval of the Jarvik 2000 Destination Therapy Trial

August 14, 2012

Advertisement

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

LV to Aorta Pumping: HeartMate PHP

HeartMate Percutaneous Heart Pump (PHP) in Cardiogenic Shock Initial Clinical Experience From Prague

HeartMate Percutaneous Heart Pump (PHP) in High-Risk Coronary Intervention: Results of the SHIELD I Trial

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

Thoratec Receives CE Mark Approval For HeartMate PHP™

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

Thoratec Announces Start Of The HeartMate PHP™ CE Mark Trial

JARVIK HEART Announces Full FDA Approval of the Jarvik 2000 Destination Therapy Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content